1. Home
  2. KNRX vs IOBT Comparison

KNRX vs IOBT Comparison

Compare KNRX & IOBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

KNRX

KNOREX LTD. Class A Ordinary Shares

N/A

Current Price

$1.54

Market Cap

50.5M

Sector

Technology

ML Signal

N/A

Logo IO Biotech Inc.

IOBT

IO Biotech Inc.

HOLD

Current Price

$0.74

Market Cap

57.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KNRX
IOBT
Founded
2009
2014
Country
Singapore
Denmark
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
50.5M
57.2M
IPO Year
2025
2021

Fundamental Metrics

Financial Performance
Metric
KNRX
IOBT
Price
$1.54
$0.74
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
$3.50
AVG Volume (30 Days)
17.4K
766.9K
Earning Date
01-28-2026
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$10,820,365.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
24.00
N/A
52 Week Low
$1.25
$0.32
52 Week High
$4.00
$2.79

Technical Indicators

Market Signals
Indicator
KNRX
IOBT
Relative Strength Index (RSI) N/A 47.19
Support Level N/A $0.61
Resistance Level N/A $0.75
Average True Range (ATR) 0.00 0.07
MACD 0.00 0.00
Stochastic Oscillator 0.00 36.33

Price Performance

Historical Comparison
KNRX
IOBT

About KNRX KNOREX LTD. Class A Ordinary Shares

Knorex Ltd is a B2B technology company providing programmatic advertising products and solutions to marketers to streamline and automate their advertising and marketing workflows. Its software offers marketers cost-effective solutions and productivity-enhancing capabilities to target audience across various advertising channels and devices through automated processes and algorithms, which is known as programmatic advertising. Its product, Knorex XPOSM, is a self-service enterprise-grade cloud platform with a suite of advertising management and execution (AMX) applications. The Company operates in one operating segment, which focuses on platform subscription fee, platform services, managed activations, and professional services.

About IOBT IO Biotech Inc.

IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.

Share on Social Networks: